BACE1 and Alzheimer disease: Similarly, the inhibition of BACE1 would be much less effective in delaying/slowing down AD in the elderly, as a consequence of a more advanced stage of pre-clinical/clinical AD, ageing brain, lower impact of BACE1 in AD pathogenesis in the elderly or longer time for possible regression of the disease.